Marjan Ghiyasvand, Ardeshir Hesampour, Hossein Dabiri, Javad Arasteh
{"title":"Anticancer Effects of <i>Escherichia Coli</i>-Derived Outer Membrane Vesicles Against Colorectal Cancer.","authors":"Marjan Ghiyasvand, Ardeshir Hesampour, Hossein Dabiri, Javad Arasteh","doi":"10.61186/rbmb.13.3.438","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>One of the deadliest cancers in the world, colorectal cancer has a dismal prognosis and a poor response to therapy. It was suggested that outer membrane vesicles (OMVs) produced by <i>Escherichia coli (E. coli)</i> are a powerful inducer of inflammation in intestinal epithelial cells. This research aimed to determine the anticancer potential of <i>E. coli</i>-derived OMVs using a colorectal cancer model.</p><p><strong>Methods: </strong>Five distinct <i>E. coli</i> strains were collected for this study. Their OMVs were then isolated and characterized using dynamic light scattering (DLS) and scanning electron microscopy (SEM). The effects of <i>E. coli</i>-derived OMVs on colorectal cancer were evaluated in vitro and in vivo using a colorectal tumor model in nude mice.</p><p><strong>Results: </strong>Obtained results showed that <i>E. coli</i> probiotic strains released spherical-shaped vesicles ranging from 5 to 200 nm. <i>E. coli</i>-derived OMVs showed that in the untreated group, a large portion of the tumor tissue continued to grow, with only a few cells undergoing apoptosis. Conversely, the OMV-treated group exhibited a higher number of apoptotic cells, highlighting the anticancer effects of E. coli-derived OMVs in colorectal cancer.</p><p><strong>Conclusions: </strong>These results demonstrated that <i>E. coli</i>-derived OMVs can be employed as a potential treatment for colorectal cancer with minimal adverse effects. Mechanistic studies indicate that these vesicles may promote apoptosis and inhibit cell proliferation, supporting their therapeutic potential.</p>","PeriodicalId":45319,"journal":{"name":"Reports of Biochemistry and Molecular Biology","volume":"13 3","pages":"438-444"},"PeriodicalIF":1.2000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12050064/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Biochemistry and Molecular Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.61186/rbmb.13.3.438","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: One of the deadliest cancers in the world, colorectal cancer has a dismal prognosis and a poor response to therapy. It was suggested that outer membrane vesicles (OMVs) produced by Escherichia coli (E. coli) are a powerful inducer of inflammation in intestinal epithelial cells. This research aimed to determine the anticancer potential of E. coli-derived OMVs using a colorectal cancer model.
Methods: Five distinct E. coli strains were collected for this study. Their OMVs were then isolated and characterized using dynamic light scattering (DLS) and scanning electron microscopy (SEM). The effects of E. coli-derived OMVs on colorectal cancer were evaluated in vitro and in vivo using a colorectal tumor model in nude mice.
Results: Obtained results showed that E. coli probiotic strains released spherical-shaped vesicles ranging from 5 to 200 nm. E. coli-derived OMVs showed that in the untreated group, a large portion of the tumor tissue continued to grow, with only a few cells undergoing apoptosis. Conversely, the OMV-treated group exhibited a higher number of apoptotic cells, highlighting the anticancer effects of E. coli-derived OMVs in colorectal cancer.
Conclusions: These results demonstrated that E. coli-derived OMVs can be employed as a potential treatment for colorectal cancer with minimal adverse effects. Mechanistic studies indicate that these vesicles may promote apoptosis and inhibit cell proliferation, supporting their therapeutic potential.
期刊介绍:
The Reports of Biochemistry & Molecular Biology (RBMB) is the official journal of the Varastegan Institute for Medical Sciences and is dedicated to furthering international exchange of medical and biomedical science experience and opinion and a platform for worldwide dissemination. The RBMB is a medical journal that gives special emphasis to biochemical research and molecular biology studies. The Journal invites original and review articles, short communications, reports on experiments and clinical cases, and case reports containing new insights into any aspect of biochemistry and molecular biology that are not published or being considered for publication elsewhere. Publications are accepted in the form of reports of original research, brief communications, case reports, structured reviews, editorials, commentaries, views and perspectives, letters to authors, book reviews, resources, news, and event agenda.